SCHEMBL2373111

SCHEMBL2373111

CNS(=O)(=O)c1ccc(OC(F)F)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.63
LMNA P02545 2/20 0.63
HTT P42858 1/20 0.63
ALDH3A1 P30838 1/20 0.58
GAA P10253 1/20 0.52
CA1 P00915 3/20 0.50
CA2 P00918 3/20 0.50
CA12 O43570 2/20 0.50
CA3 P07451 2/20 0.50
CA4 P22748 2/20 0.50
CA6 P23280 2/20 0.50
CA5A P35218 2/20 0.50
CA7 P43166 2/20 0.50
CA9 Q16790 2/20 0.50
CA13 Q8N1Q1 2/20 0.50
CA14 Q9ULX7 2/20 0.50
CA5B Q9Y2D0 2/20 0.50
ALDH1A1 P00352 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.44
ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9978287 0.83 SMN1; SMN2 (0.66) SMN1; SMN2LMNAHTTALDH3A1GAA
SCHEMBL2373108 0.81 ALOX15 (0.43) SMN1; SMN2LMNAHTTALDH3A1CA1
SCHEMBL2284446 0.81 SMN1; SMN2 (0.58) SMN1; SMN2LMNAHTTALDH3A1GAA
SCHEMBL2284914 0.80 SMN1; SMN2 (0.56) SMN1; SMN2LMNAHTTALDH3A1GAA
SCHEMBL28212268 0.80 FBP1 (0.50) SMN1; SMN2LMNAHTTALDH3A1L3MBTL1
SCHEMBL5338319 0.79 ALDH3A1 (0.43) SMN1; SMN2LMNAHTTALDH3A1CA1
SCHEMBL5338328 0.79 DRD1 (0.46) SMN1; SMN2LMNAHTTALDH3A1ALDH1A1
SCHEMBL13211115 0.79 ENPP2 (0.45) LMNAHTTALDH3A1ALDH1A1ALOX15
SCHEMBL17907417 0.78 SMN1; SMN2 (1.00) SMN1; SMN2LMNAHTTGAACA1
SCHEMBL2371138 0.77 FFAR4 (0.43) SMN1; SMN2LMNAALDH3A1ALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2547204-A2 ARYL AND HETARYL SULFONAMIDES AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS Bayer Intellectual Property GmbH (DE) 2013-01-23 EP claimed
US-20110230350-A1 ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 US claimed
WO-2011113861-A2 ARYL AND HETARYL SULFONAMIDES AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 WO claimed
EP-2547204-A2 ARYL AND HETARYL SULFONAMIDES AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS Bayer Intellectual Property GmbH (DE) 2013-01-23 EP disclosed
US-20110230350-A1 ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 US disclosed
WO-2011113861-A2 ARYL AND HETARYL SULFONAMIDES AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230350-A1 ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS STS, ARSA, TST SMN1; SMN2 4603/4885LMNA 4502/4885HTT 959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.